Skip to content

GeneDx Holdings

US · WGS #2702 by market cap Listed 1970
45.46 -3.78 -7.68%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 7 in the most recent period (2026/Q3).
  • Total institutional ownership fell 1.0 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
107.83% -1.04pp
Institutions
279 -7
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund51.90%
Hedge Fund25.19%
VC/PE Fund14.84%
Public Company11.47%
Private Company2.49%
Individual/Insider1.85%
Sovereign Wealth Fund0.91%
Government Pension Fund0.68%
Insurance Company0.30%

Top holders as of 2026-06-30

Corvex Management LP 15.96% · 4.78M sh
Casdin Capital, LLC 12.37% · 3.71M sh
ARK Investment Management LLC 6.38% · 1.91M sh
BlackRock 5.65% · 1.69M sh
The Goldman Sachs Group, Inc. 5.45% · 1.63M sh
William Blair Investment Management, LLC 5.33% · 1.60M sh
Morgan Stanley 3.39% · 1.01M sh
Vanguard Capital Management, LLC 3.17% · 948.76K sh
Citadel Advisors LLC 2.89% · 865.46K sh
First Light Asset Management, LLC 2.62% · 783.92K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 34 buys · 16 sells

NameRoleStake
Corvex Management LP -- 15.96%
Casdin Capital, LLC -- 12.37%
Joshua Ruch Independent Director 0.52%
Jason Ryan Former Chairperson 0.40%
Katherine Stueland Chief Executive Officer 0.39%
Richard Pfenniger Independent Director 0.15%
Kevin Feeley Chief Financial Officer 0.15%
Emily Leproust Independent Director 0.08%
Eli Casdin Independent Director 0.08%
Keith Meister Independent Chairperson 0.08%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-16 Thomas Fuchs Independent Director Derivative Exercise and Retained +1,146 --
2026-09-15 Katherine Stueland Chief Executive Officer Derivative Exercise and Sale -10,501 $94.26–99.00
2026-09-15 Katherine Stueland Chief Executive Officer Derivative Exercise and Retained +8,249 --
2026-09-15 Kevin Feeley Chief Financial Officer Derivative Exercise and Sale -3,728 $94.26–99.00
2026-09-15 Kevin Feeley Chief Financial Officer Derivative Exercise and Retained +3,469 --
2026-09-08 Katherine Stueland Chief Executive Officer Derivative Exercise and Sale -3,692 $84.22
2026-09-08 Katherine Stueland Chief Executive Officer Derivative Exercise and Retained +2,855 --
2026-09-08 Kevin Feeley Chief Financial Officer Derivative Exercise and Sale -1,285 $84.22
2026-09-08 Kevin Feeley Chief Financial Officer Derivative Exercise and Retained +1,177 --
2026-08-31 Kevin Feeley Chief Financial Officer Derivative Exercise and Sale -372 $83.84
2026-08-31 Kevin Feeley Chief Financial Officer Derivative Exercise and Retained +345 --
2026-06-28 Mark Gardner President Other Derivative Acquisition +35,441 --
2026-06-17 Rho Capital Partners, Inc. -- Other Derivative Acquisition +4,248 --
2026-06-17 Rho Capital Partners, Inc. -- Derivative Exercise and Retained +3,576 --
2026-06-17 Richard Pfenniger Independent Director Other Derivative Acquisition +4,248 --
2026-06-17 Richard Pfenniger Independent Director Derivative Exercise and Retained +3,576 --
2026-06-17 Keith Meister Independent Chairperson Other Derivative Acquisition +4,248 --
2026-06-17 Keith Meister Independent Chairperson Derivative Exercise and Retained +3,576 --
2026-06-17 Eli Casdin Independent Director Other Derivative Acquisition +4,248 --
2026-06-17 Eli Casdin Independent Director Derivative Exercise and Retained +3,576 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

GeneDx Holdings discussion 0 comments

Add a comment